This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Continue
Learn More

Some cookies on this site are essential, and the site won't work as expected without them. These cookies are set when you submit a form, login or interact with the site by doing something that goes beyond clicking on simple links.

We also use some non-essential cookies to anonymously track visitors or enhance your experience of the site.

To control third party cookies, you can also adjust your browser settings.

Oxford Radcliffe Hospitals get IT vaccine

Sophos has won a contract worth £20,000 to supply Oxford Radcliffe Hospitals NHS Trust as part of its new NHS licensing policy.

The Trust is using the technology to protect patient-based information systems and essential clinical data. This includes mission-critical information stored electronically, from finance departments to operating theatres.

Oxford Radcliffe previously used various virus protection packages over a mixed environment of Macintoshes and PCs. It put the contract out to tender to consolidate on a single solution which could be managed across all their desktops on four separate hospital sites.

"We have a responsibility to protect patient data to the highest possible standards," said Nick Atkins, assistant director, information management and technology at the Oxford Radcliffe Hospitals. "Sophos has provided an easy to manage, cross-platform anti-virus solution which is updated regularly. It also offers the comprehensive range of services we feel are necessary to support our IT function in delivering this solution, from installation to training and technical support."

"Anti-virus protection continues to be a high priority for public sector agencies and this is reflected in the increasing number of enquiries we are receiving," said Paul Ducklin, head of research at Sophos. "The NHS and government departments are responsible for handling so much of the population's sensitive data, it is natural they should take IT procurement seriously."

About Sophos

More than 100 million users in 150 countries rely on Sophos’ complete security solutions as the best protection against complex threats and data loss. Simple to deploy, manage, and use, Sophos’ award-winning encryption, endpoint security, web, email, mobile and network security solutions are backed by SophosLabs - a global network of threat intelligence centers. Sophos is headquartered in Oxford, U.K., and is publicly traded on the London Stock Exchange under the symbol “SOPH.” More information is available at www.sophos.com/company.